IRTC
Irhythm Holdings, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$123.37Close
$4.0BMarket cap
$101.79 – $189.2552-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 26 · weaker than 74% of stocks over 12 months
- Far from its high 35% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
35%
1wk
up 1.7%
price change
1mo
up 8.5%
price change
12-month return
down 33%
market up 11% ·
its own down 44%
F-score
5 / 9
Mixed
Altman Z
2.85
Moderate risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
26.1×
price / book
Earnings yield
down 1.5%
EBIT / enterprise value
Cheaper than
17%
of the market · expensive
Revenue growth
up 26%
year on year
EPS growth
—
latest quarter
Sales growth
up 20%
latest quarter · -6 pts
ROE
down 37%
return on equity
Free cash margin
up 5%
$34.5M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- short-term liquidity weakened
- issued more shares
- assets working less efficiently
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
Repair signals
- FCF turned positive ($-31M → $35M)
- Gross margin 68.9% → 70.6%
Trade setup
ATR%
3.6%
$4.42 a day · 2×ATR $114.52
RS
26 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.82
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 2 of 8
- Price above the 150 and 200-day averages: passes
- Price above the 50-day average: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 2.9% over the year, from 31m to 32m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+2% vs market2 sessions after results
Financials
- Gross 71%
- Net -6%
- Free cash 5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $265.2M | $322.8M | $410.9M | $492.7M | $591.8M | $747.1M |
| Gross margin | 73% | 66% | 69% | 67% | 69% | 71% |
| Operating income | -$43.7M | -$99.9M | -$113.8M | -$125.2M | -$115.5M | -$57.4M |
| Net income | -$43.8M | -$101.0M | -$116.0M | -$123.0M | -$113.0M | -$45.0M |
| Net margin | -17% | -31% | -28% | -25% | -19% | -6% |
| Earnings per share | -$1.58 | -$3.44 | -$3.88 | -$4.03 | -$3.62 | -$1.41 |
| Free cash flow | -$27.3M | -$65.8M | -$52.8M | -$90.5M | -$30.6M | $34.5M |
| Free cash margin | -10% | -20% | -13% | -18% | -5% | 5% |
| Cash | $88.6M | $127.6M | $78.8M | $36.2M | $419.6M | $236.0M |
| Long-term debt | $21.3M | $9.7M | $34.9M | $35.0M | — | — |
| Shareholders' equity | $341.6M | $279.5M | $239.8M | $210.1M | $90.9M | $152.7M |
| Shares outstanding | 29.02m | 29.49m | 30.19m | 30.95m | 31.39m | 32.30m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 19, 2026 | Annual ↗ | Dec 31, 2025 | 50d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 20, 2025 | Annual ↗ | Dec 31, 2024 | 51d |
| Oct 30, 2024 | Quarterly ↗ | Sep 30, 2024 | 30d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 5, 2026 | Regulation FD ↗ |
| Sep 22, 2026 | Regulation FD ↗ |
| Aug 13, 2026 | Director or officer change ↗ |
| Aug 6, 2026 | Material agreement · Unregistered share sale ↗ |
| Aug 6, 2026 | Material agreement · Results · Regulation FD ↗ |
| Jun 15, 2026 | Cybersecurity incident ↗ |
| Jun 5, 2026 | Regulation FD ↗ |
| May 28, 2026 | Director or officer change · Shareholder vote ↗ |
| Apr 30, 2026 | Results ↗ |
| Apr 1, 2026 | Auditor change ↗ |
| Mar 12, 2026 | Director or officer change · Regulation FD ↗ |
| Feb 19, 2026 | Results ↗ |